|
- 2018
动脉粥样硬化的疫苗防治策略
|
Abstract:
动脉粥样硬化是动脉壁的免疫炎症性疾病,包括针对多种内源性、外源性抗原的先天性和适应性免疫。同时,多项研究表明 免疫系统在动脉粥样硬化过程中发挥着双重作用。因此,采用免疫调节策略,激活针对相关抗原的免疫反应,有可能改变动脉粥样硬 化的自然进程。胆固醇酯转运蛋白(cholesterol ester transfer protein,CETP)在脂质代谢中发挥重要作用,是治疗动脉粥样硬化的重 要靶点。该文主要围绕 CETP 疫苗,就近年来抗动脉粥样硬化疫苗的研究进展作一综述。
:Atherosclerosis?is?an?immune-mediated?inflammatory?disease?of?the?arterial?wall,?with?both?the?innate?and?adaptive?immune?systems?responding? to?many?endogenous?and?exogenous?antigens.?Both?proatherogenic?as?well?as?atheroprotective?roles?have?been?identified?for?the?immune?system?in? atherosclerosis.?Hence,?it?is?conceivable?that?an?immuno-modulatory?strategy?via active immunization against many of these antigens could potentially alter the?natural?history?of?atherosclerosis.?Cholesterol?ester?transfer?protein?(CETP)?plays?an?important?role?in?lipid?metabolism,?suggesting?it?might?prevent? atherosclerosis.?This?review?discusses?the?recent?advances?of?vaccine?targeting?the?development?of?atherosclerosis,?mainly?about?the?CETP?targeting?vaccines